Verastem reported $-21952000 in Net Income for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Abbvie ABBV:US $ 924M 3566M
AstraZeneca AZN:LN 29568.96M 177.38M
Curis CRIS:US $ -15.94M 0.17M
Cytokinetics CYTK:US $ -19.82M 69.62M
Epizyme EPZM:US $ -35.74M 19.76M
Gilead Sciences GILD:US $ 1144M 1125M
Immunogen IMGN:US $ -62.02M 37.88M
Laboratory Of America LH:US $ 358.6M 133M
Novartis NOVN:VX SF 1694M 528M
Pfizer PFE:US $ 9905M 2042M
Tg Therapeutics TGTX:US $ -40.51M 28.5M
Verastem VSTM:US $ -21.95M 4.99M
YTE INCY:US $ 161.43M 123.44M
Ziopharm Oncology ZIOP:US $ -9.93M 0.14M